Medtronic (MDT) is selling off endovascular technology. Volcano Corporation (VOLC) will acquire Medtronic’s Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter in a deal that should close by the end of the week. Volcano will use Pioneer Plus to increase its presence in the diagnosis and treatment of peripheral arterial disease. The acquisition moves the […]
St. Jude Medical Inc. (NYSE:STJ) earns a $5.1 million win in a long-running legal battle with Volcano Corp. (NSDQ:VOLC) involving two of their subsidiaries.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The litigation was filed by LightLab Imaging, which St. Jude acquired last year, against one of its suppliers, Axson Technology, as well as Volcano Corp., a San Diego company that bought Axson in 2008. Axson and LightLab are both based in Massachusetts.
Volcano Corp. (NASDAQ:VOLC) declared victory in the latest round of a legal battle with St. Jude Medical Inc. (NYSE:STJ) subsidiary LightLab Imaging Inc. The Superior Court of Massachusetts rejected LightLab’s claims for protection of five alleged trade secrets relating to laser technologies and denied all of the coronary imaging firm’s requests for permanent injunctions, according […]
Device maker St. Jude Medical Inc. (NYSE: STJ) is once again tangling with Volcano Corp., this time in a patent dispute over guide wires. St. Jude has filed a lawsuit against Volcano, alleging that the San Diego company infringed on five patents related to its PressureWire technology platform for guide wires, according to a statement […]
Volcano Corporation, a San Diego-based medical device manufacturer, purchased Lumen's Xtract catheter for an undisclosed sum. The company had been Xtract's exclusive global distributor since May 2009.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.